Close Menu

NEW YORK (GenomeWeb) – Cepheid announced today that it has received clearance from the US Food and Drug Administration for its Xpert MRSA NxG, a test for methicillin-resistant Staphylococcus aureus (MRSA) infection.

The test runs on the GeneXpert molecular diagnostic system and delivers results in around an hour, the company noted. To develop the test, Cepheid used an extensive library of MRSA strains collected around the world, and it included updated PCR primers and probes that detect both mecA and mecC strains, which reduces the frequency of false-positive results.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
24

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.

Nov
14
Sponsored by
Qiagen

This webinar will discuss some of the issues laboratories face when transitioning to next-generation sequencing, and the key features to be considered for a successful implementation in routine testing.

Dec
02
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.